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bstract
A novel series of 5,5-dimethyl-11-phenyl-4b,5,5a,10,10a,11,11a,12-octahydro-10,11,12-triaza-indeno[2,1-b]fluorenes 3a–3l
ere prepared by reacting oxindole, aryl amines and acetone using dibutylamine as an organocatalyst via simultaneous Kno-
venagel and Michael-type reactions. This preparation is environmentally benign, highly compatible and conveniently carried out
n ethanol under mild conditions. The structures of the new compounds were determined by spectroscopic techniques, including IR,
H NMR, 13C NMR and LCHRMS. Docking studies against an enoyl acyl carrier protein reductase predicted that the compounds
ossessed high binding affinity towards target molecules. The compound 3k  (MIC, 40 g/mL) showed comparable activity with
soniazid at the same concentrations against MT H37 Rv.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of Taibah University. This is an open access article under
es/by-
 Dibutyhe CC BY-NC-ND license (http://creativecommons.org/licens
eywords: Green synthesis; Knoevenagel–Michael addition reaction;
.  Introduction
Tuberculosis (TB) is considered an intractable dis-
ase and a major cause of death worldwide. On average,
pproximately 100 million people are affected with
B annually. TB accounts for approximately 3 millionPlease cite this article in press as: G.A. Khan, et al. A facile synt
agents, J. Taibah Univ. Sci. (2016), http://dx.doi.org/10.1016/j.jtusc
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lamine; Antitubercular activity; Molecular docking
deaths globally every year [1]. Recently, a tremendous
increase in the number of TB cases has been attributed
to two factors: a 100-fold increase among HIV-infected
patients and increased drug resistance by some bacterial
strains. A few studies have reported that a few bacterial
strains have developed drug resistance to as many as nine
drugs [2]. Primary anti-TB drugs, such as Isonicotinic
acid hydrazide (INH), streptomycin, and ethambutol,
have been ineffective in dealing with some bacterial
strains. These strains have evolved into extreme drug
resistant (XDR-TB) and multidrug resistant (MDR-TB)hesis of novel indole derivatives as potential antitubercular
i.2016.09.002
behalf of Taibah University. This is an open access article under the
virulent forms due to partial or inadequate drug therapy.
This increase in the number of antibiotic-resistant bacte-
ria has prompted the WHO to declare TB a major global
killer [3,4]. Antitubercular drugs act by inhibiting the cell
 IN+Model
 UniverARTICLEJTUSCI-329; No. of Pages 12
2 G.A. Khan et al. / Journal of Taibah
wall growth of target bacterial strains [5]. These drugs
block the biosynthesis of type II mycoloic fatty acids (a
vital component in bacterial cell walls) by controlling
the activity of specific enzymes (e.g., NADH enoylase-
reductase) necessary for cell wall formation [6].
Natural products are the main source of inspiration in
the design and synthesis of new drug molecules. Most
of these natural products comprise heterocyclic cores.
Among nitrogen-containing heterocycles, indole is a
ubiquitous structural motif of a number of natural prod-
ucts, such as rutaecarpine, horsfilline, spirotryprostatin
B, and cryptosnguinolentine (Fig. 1). The indole moiety
has been employed in the designing of new heterocyclic
compounds with diverse biological and pharmacolog-
ical properties, including antimicrobial, antitubercular,
antimalarial, antitubulin, -glucosidase inhibiting, and
antioxidative properties, and fluorescent metal probes for
molecular recognition [7–13]. However, indole deriva-
tives bearing ferrocene moieties and carboxylate chains
have been found to exhibit potent anticancer, cytotoxic
and antiviral [7,14–17] properties.
Multi-component reactions (MCRs) are of immensePlease cite this article in press as: G.A. Khan, et al. A facile synt
agents, J. Taibah Univ. Sci. (2016), http://dx.doi.org/10.1016/j.jtusc
importance in the field of medicinal chemistry. MCRs
assemble several reacting precursors in a single
step transformation with no need for intermediate
isolation; their purification results in a desirable
Fig. 1. Structures of some natural prod PRESS
sity for Science xxx (2016) xxx–xxx
bioactive heterocyclic product [15,17–19]. High atom-
economy, mild conditions, structural complexity and
environmentally benign syntheses of a few valuable
heterocyclic scaffolds have been the most advanta-
geous features encountered in MCRs [5,20]. These
properties encouraged us to synthesize a novel series
of 5,5-dimethyl-11-phenyl-4b,5,5a,10,10a,11,11a,12-
octahydro-10,11,12-triaza-indeno[2,1-b]fluorenes
3a–3l  (Scheme 1) as molecular templates capable of
withstanding challenges in medicinal chemistry.
There is a global need to develop new drugs which
could be effective against resistant bacterial strains. In
this study, we report on the synthesis and antitubercular
nature of the compounds 3a–l. Among the various tar-
gets for anti-TB drugs, enoyl-acyl carrier protein (ACP)
reductase is a well-established target [21,22] and was
used for docking simulations. ACP reductase is a key
enzyme for the synthesis of type II fatty acids.
2.  Experimental
2.1.  Chemicals  and  apparatushesis of novel indole derivatives as potential antitubercular
i.2016.09.002
Chemicals purchased from Sigma-Aldrich (Mumbai,
Maharashtra, India), Himedia (Mumbai, Maharashtra,
India), CDH (Lucknow, U.P. India) and Merck (Mumbai,
ucts containing indole nucleus.
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3Scheme 1. Dibutyl amine catalyzed one pot three 
aharashtra, India) were used without further purifi-
ation. Melting points were determined using an open
apillary tube melting point apparatus and are pre-
ented without any corrections. Infrared (IR) spectra
ere recorded on a FTIR (Shimadzu, Japan) Shimadzu-
400S spectrometer using KBr pellets. 1H NMR (Bruker
vance, Germany) and 13C NMR spectra were recorded
n a Bruker Avance 500 spectrometer using tetram-
thylsilane (TMS) as an internal standard and CDCl3 as
 solvent. LCHRMS (Bruker Microtoff-QII, Germany)
as determined on a Bruker Microtoff-QII 10330 mass
pectrometer. The purity of the compounds were checked
y TLC using Merck pre-coated silica gel, GF alu-
inium plates, and a methanol:chloroform:ethyl acetate
1:3:5) solvent system.
.2.  General  one  pot  synthesis  of
,5-dimethyl-11-phenyl-4b,5,5a,10,10a,11,11a,12-
ctahydro-10,11,12-triaza-indeno[2,1-b]ﬂuorenes
3a–l)
An ethanolic solution of oxindole (2 mmol) and ani-
ine (1 mmol) in the presence of dibutylamine (10 mol%)
as refluxed for a specified time period (or stirred at
oom temperature). Then, 4 mL of acetone were added.
he mixture was again refluxed (or stirred at room tem-
erature) until reaction completion (monitored by TLC).
he obtained precipitate obtained was filtered and suc-
essively washed with water and hexane. The precipitate
as then recrystallised from ethanol and vacuum dried
o obtain a pure product (3a–l). Subsequently, the prod-
ct structure was confirmed by IR, 1H NMR, 13C NMR
nd LCHRMS.
.2.1.
,5-Dimethyl-11-phenyl-4b,5,5a,10,10a,11,11a,12-
ctahydro-10,11,12-triaza-indeno[2,1-b]ﬂuorenes
3a)
−1Please cite this article in press as: G.A. Khan, et al. A facile synt
agents, J. Taibah Univ. Sci. (2016), http://dx.doi.org/10.1016/j.jtusc
IR (KBr) (νmax cm ): 1090 (C–C), 1247 (C–N),
560 (C C), 3090 (C–H), 3405 (N–H). 1H NMR
500 MHz, CDCl3, TMS, δ ppm): 1.8 (s, 6H, CH3),
.4 (s, 2H, CH), 3.9 (s, 2H, CH), 6.6 (d, J  = 5 Hz, 2H,ent reaction of oxindole, aryl amine and acetone.
HAr), 6.9 (m, 5H, HAr), 7.4 (d, J = 4.5 Hz, 2H, HAr), 7.5
(t, J  = 12 Hz, 2H, HAr), 7.7 (t, J  = 8 Hz, 2H, HAr), 8.9
(s, 2H, NH); 13C NMR (125 MHz, CDCl3, δ ppm) δc:
26.7, 35.9, 56.7, 76.7, 109.4, 112.5, 115.5, 121.5, 123.1,
124.3, 127.5, 136.4, 139.4, 155.5. LCHRMS (ESI): m/z
[M+H]+: 368.2059 (Supplementary Figs. S1–S3).
2.2.2.
5,5-Dimethyl-11-o-tolyl-4b,5,5a,10,10a,11,11a,12-
octahydro-10,11,12-triaza-indeno[2,1-b]ﬂuorene
(3b)
IR (KBr) (νmax cm−1): 1093 (C–C), 1242 (C–N),
1552 (C C), 3090 (C–H), 3405 (N–H). 1H NMR
(500 MHz, CDCl3, TMS, δ  ppm): 1.8 (s, 6H, CH3), 2.1
(s, 3H, CH3), 3.4 (s, 2H, CH), 3.9 (s, 2H, CH), 6.6 (d,
J = 5 Hz, 2H, HAr), 6.8 (d, J  = 9.2 Hz, 1H, HAr), 6.9 (t,
J = 3.7 Hz, 1H, HAr), 7.1 (t, J  = 6.3 Hz, 1H, HAr), 7.1 (t,
J = 5.1 Hz, 1H, HAr), 7.4 (d, J  = 4.5 Hz, 2H, HAr), 7.5 (t,
J = 12 Hz, 2H, HAr), 7.7 (t, J  = 8 Hz, 2H, HAr), 8.9 (s,
2H, NH); 13C NMR (125 MHz, CDCl3, δ  ppm) δc: 24.3
26.7, 35.9, 56.7, 76.7, 109.4, 114.1, 115.5, 119.1, 123.1,
124.3, 129.4, 136.4, 140.7, 155.5. HRLCMS (ESI): m/z
[M+H]+: 382.2459.
2.2.3.  11-(2-Ethyl-phenyl)-5,5-dimethyl-
4b,5,5a,10,10a,11,11a,12-octahydro-10,11,12-
triaza-indeno[2,1-b]ﬂuorene
(3c)
IR (KBr) (νmax cm−1): 1090 (C–C), 1242 (C–N),
1565 (C C), 3095 (C–H), 3405 (N–H). 1H NMR
(500 MHz, CDCl3, TMS, δ ppm): 1.3 (t, J  = 9.1 Hz,
3H, CH3), 1.8 (s, 6H, CH3), 2.1 (q, J  = 5.9 Hz, 2H,
HAr), 3.4 (s, 2H, CH), 3.9 (s, 2H, CH), 6.6 (d,
J = 5 Hz, 2H, HAr), 6.9 (d, J  = 3.7 Hz, 1H, HAr), 7.1
(t, J = 8.1 Hz, 1H, HAr), 7.2 (d, J  = 6.1 Hz, 1H, HAr),
7.4 (d, J = 4.5 Hz, 2H, HAr), 7.5 (t, J  = 12 Hz, 2H,
HAr), 7.7 (t, J = 8 Hz, 2H, HAr), 7.9 (t, J  = 5.3 Hz,
1H, HAr), 8.9 (s, 2H, NH); 13C NMR (125 MHz,hesis of novel indole derivatives as potential antitubercular
i.2016.09.002
CDCl3, δ  ppm) δc: 26.7, 35.9, 56.7, 76.7, 109.4,
111.9, 113, 115.5, 121.4, 122.8, 123.1, 124.3, 125.3,
136.4, 141.3, 155.5. LCHRMS (ESI): m/z  [M+H]+:
396.2459.
 IN+Model
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2.2.4.  11-(4-Chloro-phenyl)-5,5-dimethyl-
4b,5,5a,10,10a,11,11a,12-octahydro-10,11,12-
triaza-indeno[2,1-b]ﬂuorene
(3d)
IR (KBr) (νmax cm−1): 744 (C–Cl), 1097 (C–C), 1247
(C–N), 1568 (C C), 3090 (C–H), 3405 (N–H). 1H NMR
(500 MHz, CDCl3, TMS, δ ppm): 1.8 (s, 6H, CH3),
3.4 (s, 2H, CH), 3.9 (s, 2H, CH), 6.6 (d, J = 5 Hz, 2H,
HAr), 6.7 (d, J = 11.3 Hz, 2H, HAr), 7.4 (d, J  = 4.5 Hz,
2H, HAr), 7.5 (t, J = 12 Hz, 2H, HAr), 7.6 (d, J = 8.4 Hz,
2H, HAr), 7.7 (t, J  = 8 Hz, 2H, HAr), 8.9 (s, 2H, NH);
13C NMR (125 MHz, CDCl3, δ  ppm) δc: 26.7, 35.9,
56.7, 76.7, 109.4, 116.4, 115.5, 123.1, 124.3, 126.3,
131.8, 136.4, 148, 155.5. LCHRMS (ESI): m/z  [M+H]+:
402.2459.
2.2.5. 5,5-Dimethyl-11-(4-nitro-phenyl)-
4b,5,5a,10,10a,11,11a,12-octahydro-10,11,12-
triaza-indeno[2,1-b]ﬂuorene
(3e)
IR (KBr) (νmax cm−1): 1103 (C–C), 1247 (C–N),
1571 (C C), 3090 (C–H), 3405 (N–H). 1H NMR
(500 MHz, CDCl3, TMS, δ ppm): 1.8 (s, 6H, CH3),
3.4 (s, 2H, CH), 3.9 (s, 2H, CH), 6.6 (d, J = 5 Hz, 2H,
HAr), 7.0 (d, J  = 9.5 Hz, 2H, HAr), 7.4 (d, J = 4.5 Hz, 2H,
HAr), 7.5 (t, J = 12 Hz, 2H, HAr), 7.7 (t, J = 8 Hz, 2H,
HAr), 7.9 (d, J = 6.9 Hz, 2H, HAr), 8.9 (s, 2H, NH); 13C
NMR (125 MHz, CDCl3, δ  ppm) δc: 26.7, 35.9, 56.7,
76.7, 109.4, 114.1, 115.5, 121.5, 123.1, 124.3, 136.4,
142.1, 152.8, 155.5. LCHRMS (ESI): m/z  [M+H]+:
413.2459.
2.2.6. 5,5-Dimethyl-11-(2-nitro-phenyl)-
4b,5,5a,10,10a,11,11a,12-octahydro-10,11,12-
triaza-indeno[2,1-b]ﬂuorene
(3f)
IR (KBr) (νmax cm−1): 1090 (C–C), 1247 (C–N),
1569 (C C), 3090 (C–H), 3405 (N–H). 1H NMR
(500 MHz, CDCl3, TMS, δ ppm): 1.8 (s, 6H, CH3),
3.4 (s, 2H, CH), 3.9 (s, 2H, CH), 6.6 (d, J = 5 Hz, 2H,
HAr), 6.7 (d, J  = 4.3 Hz, 1H, HAr), 6.8 (t, J  = 8.3 Hz, 1H,
HAr), 7.0 (t, J  = 6.4 Hz, 1H, HAr), 7.4 (d, J  = 4.5 Hz, 2H,
HAr), 7.5 (t, J = 12 Hz, 2H, HAr), 7.7 (t, J = 8 Hz, 2H,
HAr), 7.9 (d, J = 7.6 Hz, 1H, HAr), 8.9 (s, 2H, NH); 13CPlease cite this article in press as: G.A. Khan, et al. A facile synt
agents, J. Taibah Univ. Sci. (2016), http://dx.doi.org/10.1016/j.jtusc
NMR (125 MHz, CDCl3, δ  ppm) δc: 26.7, 35.9, 56.7,
76.7, 109.4, 112.8, 115.5, 119.7, 123.1, 124.3, 128.5,
137.3, 136.4, 139.1, 139.6, 155.5. LCHRMS (ESI): m/z
[M+H]+: 413.2459. PRESS
sity for Science xxx (2016) xxx–xxx
2.2.7.  2,8-Dichloro-5,5-dimethyl-11-phenyl-
4b,5,5a,10,10a,11,11a,12-octahydro-10,11,12-
triaza-indeno[2,1-b]ﬂuorene
(3g)
IR (KBr) (νmax cm−1): 744.9 (C–Cl), 1090 (C–C),
1247 (C–N), 1560 (C C), 3090 (C–H), 3405 (N–H).
1H NMR (500 MHz, CDCl3, TMS, δ  ppm): 1H NMR
(500 MHz, CDCl3, TMS, δ ppm): 1.8 (s, 6H, CH3),
3.4 (s, 2H, CH), 3.9 (s, J = 75 Hz, 2H, CH), 6.7(s, 2H,
HAr), 6.9 (m, 5H, HAr), 7.3 (d, J = 8.1 Hz, 2H, HAr),
7.6 (d, J  = 4.3 Hz, 2H, HAr), 8.9 (s, 2H, NH); 13C NMR
(125 MHz, CDCl3, δ ppm) δc: 26.7, 35.9, 56.7, 76.7,
110.8, 112.5, 117.4, 121.5, 122.9, 127.5, 134.7, 138.2,
139.4, 156.3. LCHRMS (ESI): m/z  [M+H]+: 436.1459.
2.2.8. 2,8-Dichloro-5,5-dimethyl-11-o-tolyl-
4b,5,5a,10,10a,11,11a,12-octahydro-10,11,12-
triaza-indeno[2,1-b]ﬂuorene
(3h)
IR (KBr) (νmax cm−1): 744.9 (C–Cl), 1093 (C–C),
1242 (C–N), 1552 (C C), 3090 (C–H), 3405 (N–H).
1H NMR (500 MHz, CDCl3, TMS, δ  ppm): 1H NMR
(500 MHz, CDCl3, TMS, δ  ppm): 1.8 (s, 6H, CH3), 2.1
(s, 3H, CH3), 3.4 (s, 2H, CH), 3.9 (s, 2H, CH), 6.7(s, 2H,
HAr), 6.8 (d, J = 9.2 Hz, 1H, HAr), 6.9 (t, J = 3.7 Hz, 1H,
HAr), 7.1 (t, J = 6.3 Hz, 1H, HAr), 7.1 (t, J  = 5.1 Hz, 1H,
HAr), 7.3 (d, J  = 8.1 Hz, 2H, HAr), 7.6 (d, J  = 4.3 Hz, 2H,
HAr), 8.9 (s, 2H, NH); 13C NMR (125 MHz, CDCl3,
δ ppm) δc: 24.3 26.7, 35.9, 56.7, 76.7, 110.8, 114.1,
117.4, 119.1, 122.9, 129.4, 134.7, 138.2, 140.7, 156.3.
LCHRMS (ESI): m/z  [M+H]+: 450.1759.
2.2.9.  2,8-Dichloro-11-(2-ethyl-phenyl)-5,5-
dimethyl-4b,5,5a,10,10a,11,11a,12-octahydro-
10,11,12-triaza-indeno[2,1-b]ﬂuorene
(3i)
IR (KBr) (νmax cm−1): 744.9 (C–Cl), 1090 (C–C),
1242 (C–N), 1565 (C C), 3095 (C–H), 3405 (N–H).
1H NMR (500 MHz, CDCl3, TMS, δ  ppm): 1H NMR
(500 MHz, CDCl3, TMS, δ  ppm): 1.3 (t, J = 9.1, 3H,
CH3), 1.8 (s, 6H, CH3), 2.1 (q, J = 5.9 Hz, 2H, HAr),
3.4 (s, 2H, CH), 3.9 (s, 2H, CH), 6.7(s, 2H, HAr), 6.9
(d, J  = 3.7 Hz, 1H, HAr), 7.1 (t, J = 8.1 Hz, 1H, HAr), 7.2
(d, J  = 6.1 Hz, 1H, HAr), 7.3 (d, J  = 8.1 Hz, 2H, HAr),
7.6 (d, J  = 4.3 Hz, 2H, HAr), 7.9 (t, J  = 5.3 Hz, 1H, HAr),
13hesis of novel indole derivatives as potential antitubercular
i.2016.09.002
8.9 (s, 2H, NH); C NMR (125 MHz, CDCl3, δ  ppm)
δc: 26.7, 35.9, 56.7, 76.7, 110.8, 113, 117.4, 111.9,
121.4, 122.8, 122.9, 125.3, 134.7, 138.2, 141.3, 156.3.
LCHRMS (ESI): m/z  [M+H]+: 464.1859.
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.2.10.  2,8-Dichloro-11-(4-chloro-phenyl)-5,5-
imethyl-4b,5,5a,10,10a,11,11a,12-octahydro-
0,11,12-triaza-indeno[2,1-b]ﬂuorene
3j)
IR (KBr) (νmax cm−1): 744 (C–Cl), 1097 (C–C), 1247
C–N), 1572 (C C), 3090 (C–H), 3405 (N–H). 1H NMR
500 MHz, CDCl3, TMS, δ  ppm): 1.8 (s, 6H, CH3), 3.4
s, 2H, CH), 3.9 (s, 2H, CH), 6.7(s, 2H, HAr), 6.7 (d,
 = 11.3 Hz, 2H, HAr), 7.3 (d, J  = 8.1 Hz, 2H, HAr), 7.6
d, J  = 4.3 Hz, 2H, HAr), 7.6 (d, J  = 8.4 Hz, 2H, HAr), 8.9
s, 2H, NH); 13C NMR (125 MHz, CDCl3, δ  ppm) δc:
6.7, 35.9, 56.7, 76.7, 110.8, 116.4, 117.4, 126.3, 122.9,
31.8, 134.7, 138.2, 148, 156.3. LCHRMS (ESI): m/z
M+H]+: 470.1159.
.2.11.  2,8-Dichloro-5,5-dimethyl-11-(4-nitro-
henyl)-4b,5,5a,10,10a,11,11a,12-octahydro-
0,11,12-triaza-indeno[2,1-b]ﬂuorene
3k)
IR (KBr) (νmax cm−1): 744.9 (C–Cl), 1103 (C–C),
247 (C–N), 1571 (C C), 3090 (C–H), 3405 (N–H). 1H
MR (500 MHz, CDCl3, TMS, δ  ppm): 1.8 (s, 6H, CH3),
.4 (s, 2H, CH), 3.9 (s, 2H, CH), 6.7(s, 2H, HAr), 7.0 (d,
 = 9.5 Hz, 2H, HAr), 7.3 (d, J = 8.1 Hz, 2H, HAr), 7.6
d, J  = 4.3 Hz, 2H, HAr), 7.9 (d, J  = 6.9 Hz, 2H, HAr), 8.9
s, 2H, NH); 13C NMR (125 MHz, CDCl3, δ  ppm) δc:
6.7, 35.9, 56.7, 76.7, 110.8, 114.1, 117.4, 121.5, 122.9,
34.7, 138.2, 142.1, 152.8, 156.3. LCHRMS (ESI): m/z
M+H]+: 481.1459.
.2.12.  2,8-Dichloro-5,5-dimethyl-11-(2-nitro-
henyl)-4b,5,5a,10,10a,11,11a,12-octahydro-
0,11,12-triaza-indeno[2,1-b]ﬂuorene
3l)
IR (KBr) (νmax cm−1): 744.9 (C–Cl), 1090 (C–C),
247 (C–N), 1569 (C C), 3090 (C–H), 3405 (N–H). 1H
MR (500 MHz, CDCl3, TMS, δ  ppm): 1.8 (s, 6H, CH3),
.4 (s, 2H, CH), 3.9 (s, 2H, CH), 6.7(s, 2H, HAr), 6.7 (d,
 = 4.3 Hz, 1H, HAr), 6.8 (t, J  = 8.3 Hz, 1H, HAr), 7.0 (t,
 = 6.4 Hz, 1H, HAr), 7.3 (d, J = 8.1 Hz, 2H, HAr), 7.6
d, J = 4.3 Hz, 2H, HAr), 7.9 (d, J = 7.6 Hz, 1H, HAr),
.9 (s, 2H, NH); 13C NMR (125 MHz, CDCl3, δ  ppm)
c: 26.7, 35.9, 56.7, 76.7, 110.8, 112.8, 117.4, 119.7,
22.9, 128.5, 134.7, 137.3, 138.2, 139.1, 139.6, 156.3.
CHRMS (ESI): m/z  [M+H]+: 481.1459.
.3.  In  vitro  biological  evaluation  assayPlease cite this article in press as: G.A. Khan, et al. A facile synt
agents, J. Taibah Univ. Sci. (2016), http://dx.doi.org/10.1016/j.jtusc
.3.1.  Antitubercular  activity
A mycobacterium tuberculosis bacterial strain
MTCC CODE 300) was purchased from the Institute
f Microbial Technology (MTCC), Chandigarh (India) PRESS
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and was cultured in blood nutrient agar medium in late
logarithmic fashion (A600 nm = 1). Bacterial strains pos-
sessing plasmids adhering to an Isoniazid resistance
marker were cultured in the same medium containing
100 g/mL Isoniazid. As a control, 0.5 L bacterial
spread were streaked onto LB agar plates (25 mL agar
medium ±  90 g/mL Isoniazid discs over 9 cm Petri
plates). Filter Whatman discs (5-mm diameter) were
treated with 5 L of compound solutions, including the
reference shown in Table 3. Afterwards, the discs were
air-dried for 7–10 min and kept over the Petri plates.
These plates were incubated at 37 ◦C for approximately
48 h in a humidified chamber [23]. Subsequently, the
inhibition diameters were observed and carefully mea-
sured.
2.4.  Docking  study
A high-resolution crystal structure of enoyl-ACP
reductase was downloaded from the RCSB PDB website
(PDB ID: 1QG6) [24]. All molecular docking calcula-
tions were performed on AutoDock-Vina software (Los
Angeles, USA) [25]. The protein was prepared for dock-
ing by removing the co-crystallized ligands, water and
co-factors. An AutoDockTools (ADT) graphical user
interface was used to calculate Kollman charges and
polar hydrogen sites. Ligands were prepared for docking
by minimizing energy with a MMFF94s force field. Par-
tial charges were calculated by the Geistenger method.
Enzyme active sites were defined to include active
site residues within a 40 A˚ ×  40 A˚ ×  40 A˚ grid. The
most popular algorithm, the Lamarckian Genetic Algo-
rithm (LGA), available in AutoDock, was employed.
The docking protocol was tested by extracting the co-
crystallised inhibitor from the protein and subsequently,
docking the inhibitor. The docking protocol predicted
the same conformation present in the crystal structure.
The RMSD value was well within the predicted range of
2 A˚ (Fig. 2). Of all the explored docked conformations,
the one binding well at the active site was analyzed for
detailed interactions in Discover Studio Visualizer 4.
3.  Results  and  discussion
3.1.  Synthesis
To the best of our knowledge, this synthetic
strategy provides the first example of a facile threehesis of novel indole derivatives as potential antitubercular
i.2016.09.002
component protocol for the preparation of novel
5,5-dimethyl-11-phenyl-4b,5,5a,10,10a,11,11a,12-
octahydro-10,11,12-triaza-indeno[2,1-b]fluorenes
(3a–l). To obtain the best experimental conditions, the
Please cite this article in press as: G.A. Khan, et al. A facile synthesis of novel indole derivatives as potential antitubercular
agents, J. Taibah Univ. Sci. (2016), http://dx.doi.org/10.1016/j.jtusci.2016.09.002
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Fig. 2. (a) The docked ligand 3e (yellow) binds at the same site where co-crystallized triclosan (pink) binds. (b) Superimposition of docked
conformation (pink) over the co-crystallized conformation (yellow) of triclosan shows RMSD value close to zero, confirming the reliability of
docking protocol. (c) Detailed interactions of 3k with the inhibitor residues. Dotted lines represent the interactions. H bonds, – stacking and
alkyl– interactions are represented by green, pink and violet dotted lines respectively.
Table 1
Optimized catalyst (or additives) and solvent effects on the reaction rate and % yield of 5,5-dimethyl-11-phenyl-4b,5,10,11,11a,12-hexahydro-
10,11,12-triaza-indeno[2,1-b]fluorene (1a).
Entry Solvent Additive Catalyst Time (h) % Yield Ref.
1 DCE – Anh. FeCl3 P 10
Q 17
16
11
[26]
2 THF/HOH – Li(OH)2 P 11
Q 17
19
13
[15]
3 DMSO K2CO3 CuI P 14
Q –
12
–
[27]
4 DMSO I2 CuO P 17
Q –
23
–
[28]
5 DMF – Cs2CO3 P 14
Q –
19
–
[29]
6 CH3CN – – P 15
Q –
<7
–
[30]
7 MeOH – – P 10
Q 14
21
18
[31]
8 EtOH – Pyrollidine P 7
Q 10
35
32
[32]
9 MeOH – Anh. ZnCl2 P 7
Q 12
39
31
[7]
10 EtOH – AcOH P 9
Q 13
26
16
[33]
11 EtOH/HOH – DMAP P 9
Q 14
53
38
[34]
12 PEG/HOH – KH2PO4 P 8
Q –
47
–
[18]
13 EtOH – Dibutylamine P 1.44
Q 8.30
83
79
Present work/[35]
P, reflux condition; Q, room temperature.
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ndeno[2,1-b]fluorenes (3a–3l).
eaction conditions were optimized for the preparation
f 3a  as a model reaction at room temperature and at
eflux conditions. As depicted in Scheme 1 oxindole
nd acetone were treated with different aryl amines.
 number of solvents in the presence of a variety of
atalysts (with or without suitable additives) were used
o design the reaction media. Initially, dichloroethane
DCE), a nonpolar solvent, in presence of anhydrous
eCl3, produced 3a  with poor yields and prolonged
eaction times (Table 1; entry 1, 16%) [26]. Afterwards,
eactions were performed using polar aprotic solvents,
uch as tetrahydrofuran, dimethyl sulphoxide (DMSO),
imethyl formamide (DMF) and acetonitrile (ACN),
ith different metal catalysts, such as Li(OH)2, CuO/I2,
uI/K2CO3 and Cs2CO3. The corresponding product
ields were slightly improved at 19%, 12%, 23%, 19%
nd <7% (Table 1; entries 2–6); however, prolongedPlease cite this article in press as: G.A. Khan, et al. A facile synt
agents, J. Taibah Univ. Sci. (2016), http://dx.doi.org/10.1016/j.jtusc
eaction times were still observed [15,27–30]. The
eaction was then carried out in polar protic solvents,
uch as in methanol (MeOH), ethanol (EtOH) and
olyethylene glycol (PEG), using catalysts pyrollidine,5-dimethyl-11-phenyl-4b,5,10,11,11a,12-hexahydro-10,11,12-triaza-
anhydrous ZnCl2, AcOH, 4-dimethylaminopyridine
(DMAP) and KH2PO4. Under these conditions, the
reactions occurred smoothly with improved product
yields and reaction times. Isolated product yields were
21%, 35%, 39%, 44%, 26%, 53% and 47% (Table 1;
entries 7–12) [7,18,31–34]. This solvent screening
strategy enabled us to determine the most suitable
solvent to provide a sufficient product yield and a
reasonable reaction time. Ethanol was considered the
best solvent; in the presence of a suitable organocatalyst
(i.e., dibutylamine), the use of ethanol produced 3a
(Table 1; entry 13, 83%) at a higher yield than all other
considered solvents [35].
A potential mechanism explaining the above reac-
tion is depicted in Scheme 2. Herein, the carbonyl group
of oxindole 1  is converted into its enol form, result-
ing in the formation of 2. Intermediate 2  undergoeshesis of novel indole derivatives as potential antitubercular
i.2016.09.002
a facile nucleophilic addition from an aryl amine to
produce 4, which tautomerized to 5, which upon dehy-
dration, gives imino  intermediate  6. However, if the
oxindole was condensed with acetone, intermediate 7
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Table 2
Synthesis of phenyl-hexahydro-triaza-indeno[2,1-b]fluorenes (3a–l) in ethanol at mild reaction conditions.
Entry R R′ Protocol Time (h) Product % Yield isolated m.p. (◦C)
1 H C6H5 P
Q
8.30
1.44
3a 83 310–313
2 H o-CH3C6H5 P
Q
8.43
1.50
3b 86 298–301
3 H o-C2H5C6H5 P
Q
9.14
1.22
3c 89 319–322
4 H p-ClC6H5 P
Q
8.72
1.54
3d 85 329–332
5 H p-NO2C6H5 P
Q
8.78
1.36
3e 76 287–290
6 H o-NO2C6H5 P
Q
8.92
1.62
3f 82 307–310
7 Cl C6H5 P
Q
8.17
1.68
3g 80 326–329
8 Cl o-CH3C6H5 P
Q
8.25
1.32
3h 92 314–317
9 Cl o-C2H5C6H5 P
Q
8.35
1.48
3i 89 339–342
10 Cl p-ClC6H5 P
Q
8.35
1.44
3j 78 326–329
11 Cl p-NO2C6H5 P
Q
8.55
1.52
3k 79 343–346
12 Cl o-NO2C6H5 P
Q
9.42
1.58
3l 83 321–324
P, reflux condition; Q, room temperature.
Table 3
Lipscomb’s parameters, binding affinity and diameter of zone of inhibition (mm) for phenyl-hexahydro-triaza-indeno[2,1-b]fluorenes (3a–l).
Compound code Binding affinity log P H-bond
donors
H-bond
acceptors
Molecular
weight
Zone of inhibition
(mm)a
Minimum inhibitory
concentration
(g/mL)
3a −10.7 5.4453 4 0 368.24 13.10 ± 0.18 >160
3b −10.8 5.9443 4 0 382.24 11.2 ± 0.52 >160
3c −10.3 6.4733 4 0 396.24 7.68 ± 0.33 >160
3d −11.3 6.3291 4 0 402.24 20.19 ± 0.92 40
3e −11.2 5.5543 7 0 413.24 20.60 ± 0.96 >40
3f −9.9 5.5543 7 0 413.24 18.44 ± 0.89 80
3g −10.8 3.4713 6 2 436.14 16.18 ± 0.23 >160
3h −10.3 3.9704 6 2 450.17 17.32 ± 0.90 >160
3i −10.8 4.4993 6 2 464.18 9.11 ± 0.22 >160
3j −10.8 4.3551 6 2 470.11 20.66 ± 1.86 40
3k −11.6 3.5803 9 2 481.14 21.82 ± 1.35 40
3l −10.1 3.5803 9 2 481.14 18.39 ± 0.88 80
Isoniazid −6 −0.69 2 2 137.14 25.70 ± 0.64 10a Values are given as mean ± standard deviation (n = 3).
results via the Knoevenagel reaction in the presence
of a catalytic amount of dibutyl amine. Intermediate 7,
being a Michael acceptor, is susceptible to nucleophi-Please cite this article in press as: G.A. Khan, et al. A facile synt
agents, J. Taibah Univ. Sci. (2016), http://dx.doi.org/10.1016/j.jtusc
lic addition from 6, which acts as a Michael donor, to
yield the corresponding adduct 8. Ultimately, the sub-
sequent dehydration of intermediate 8  results in desired
compound 3.The synthesized compounds were fully character-
ized by different spectral techniques, such as IR, NMR
and HRLCMS. The IR spectrum of compound 3a
−1 −1hesis of novel indole derivatives as potential antitubercular
i.2016.09.002
exhibited sharp bands at 1090 cm and 1247 cm ,
which are assigned to C–C and C–N stretching fre-
quencies, respectively. The band at 1560 cm−1 is
attributed to C C stretching, whereas aromatic C–H
ARTICLE IN PRESS+ModelJTUSCI-329; No. of Pages 12
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tretching was observed at 3005 cm−1. In the IH
MR spectrum of 3a, three singlets were recorded
t 1.8, 3.4 and 3.9 δ  ppm due to the protons of
6/C7-CH3, C8-CH and C15-CH, indicative of a piperi-
ine ring. The proton at the C13′ position showed
 doublet at 6.6 δ ppm, whereas the aromatic pro-
ons of a phenyl ring showed a resonance multiplet
rom 6.9–7.2 δ ppm. A singlet due to indolic pro-
on was recorded at 8.9 δ ppm. The 13C NMR
f compound 3a  confirmed the number of carbonPlease cite this article in press as: G.A. Khan, et al. A facile synt
agents, J. Taibah Univ. Sci. (2016), http://dx.doi.org/10.1016/j.jtusc
toms. In this spectrum, signals approximately 26–76
 ppm were attributed to methyl and methine car-
on atoms. Peaks between 111 and 136 δ  ppm
ere assigned to aromatic carbon atoms. The twok at the active site of Enoyl-ACP reductase constructed by Ligplus.
peaks observed at 139 and 155 δ  ppm could be
attributed to carbon atoms at the C20′ and C14′
positions. These results were further confirmed by mass
spectra, which showed a molecular ion peak m/z  368
[M+H]+ in agreement with the molecular weight of the
compound.
Under optimized conditions, a number of reac-
tive ketones (i.e., butanone and 1,3-diphenylacetone)
were substituted for acetone. However, these reac-
tions had unsatisfactory results. The present strategyhesis of novel indole derivatives as potential antitubercular
i.2016.09.002
tolerated electron withdrawing and electron donating
substituents. The reactions proceeded smoothly to afford
corresponding products with desirable yields. The elec-
tron donating, alkyl-substituted anilines gave better
ARTICLE IN PRESS+ModelJTUSCI-329; No. of Pages 12
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Fig. 4. Effect on absorbance of Mycobacterium tubercular culture with different concentrations (5, 10, 20, 40, 80 and 160 g/mL) used to calculate
MIC values of compounds (3a–3l) with reference to Isoniazid taken as Standard.yields than the electron withdrawing chloro- and nitro-
substituted anilines (Table 2). This may be due to the
higher nucleophilicity of aryl amines bearing electron
donating substituents than aryl amines bearing electron-
withdrawing substituents.
3.2.  Docking  study
The docking study revealed that the synthesized
molecules bind at the same site where the co-crystallised
drug Triclosan attached (Fig. 2). Ala95 and Tyr156
formed H-bonds of lengths 2.06 and 2.97 A˚, respec-
tively, with 3e, the highest scored molecule (Fig. 3).
Met159, Ala196, Ile200, Pro191 and Ile20 were involved
in alkyl–  interactions with the   electron cloud of
the molecule (Fig. 3) [36]. These interactions and other
weak forces were responsible for the formation of a
strong ligand–macromolecule complex. These findings
predicted that the molecules had high affinity towards
bacterial enoyl-ACP reductase. The docking study pre-
dicted binding affinity values greater than −9 kcal/mol
for all ligand–ACP–reductase complexes. These resultsPlease cite this article in press as: G.A. Khan, et al. A facile synt
agents, J. Taibah Univ. Sci. (2016), http://dx.doi.org/10.1016/j.jtusc
further corroborated the earlier findings (Table 3). After
compound 3e, compounds 3i  and 3k  scored high. These
computational predictions were compared with in vitro
antitubercular activity evaluations.3.3.  In  vitro  anti  tubercular  activity
As shown in Table 3, compounds 3d, 3e  and 3k
inhibited bacterial growth to appreciable levels with
respective MIC values of 40, >40 and 40 g/mL when
using Isoniazid as a standard against mycobacterium
tuberculosis. However, the other tested compounds
showed MIC values ranging from 80 to 160 g/mL
(Table 3 and Fig. 4). No clear relation was observed
between lipophilicity (calculated log P) and MIC. Com-
pounds 3d, 3e, 3f, 3j, 3k  and 3l  were the most active
compounds and carried chloro and nitro substituents
at the para and ortho positions of the phenyl ring. In
particular, the nitro derivatives showed better activity
when compared with the chloro, methyl and ethyl deriva-
tives. Thus, the electron withdrawing groups reinforced
the antitubercular activity of the synthesized indole
derivatives (3a–l). Among the nitro derivatives (3e, 3f,
3k and 3l), the para substituted indole derivatives (3e,
3k) were more active compared with the ortho sub-
stituted derivatives. Thus, the volume and substituent
position significantly affected the biological evaluation
of a compound. The observed activity trend seemed to
be due to molecules binding at the target active site as
predicted by docking (Fig. 3). Compound 3k  showedhesis of novel indole derivatives as potential antitubercular
i.2016.09.002
better inhibition than all other compounds at the same
concentrations.
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.  Conclusion
In this study, we reported a mild and sustainable
pproach for the synthesis of 5,5-dimethyl-11-phenyl-
b,5,5a,10,10a,11,11a,12-octahydro-10,11,12-triaza-
ndeno[2,1-b]fluorene derivatives by using an MCR
rotocol. This synthesis has several advantageous
eatures, including operational simplicity, better
ields, reduced reaction times and ease of product
solation. Docking studies and in vitro antitubercular
valuations showed that the derivative compounds
3a–l) exhibited moderate to good activity against
ycobacterium  tuberculosis  strain MT H37 Rv.
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